ED
SSRI

Exane Derivatives’s Silver Standard Resources SSRI Stock Holding History

Exane Derivatives’s Portfolio SSRI Stock Details SSRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-12,034
Closed -$117K – 678
2017
Q2 		$117K Buy
12,034
+5,500
+84% +$55.2K 0.03% 259
2017
Q1 		$69.3K Buy
+6,534
New +$69.2K 0.02% 251

Other funds holding SSRI

SCP
Syntal Capital Partners Midland, Texas $10M AUM 35.51% 1-Year Est. Return

Exane Derivatives's SSRI Position: Q3 2017 in Review

Exane Derivatives sold out of Silver Standard Resources (SSRI) in Q3 2017, closing a stake of 12,034 shares — an estimated $117K sold.

Exane Derivatives first reported a position in SSRI in Q1 2017 and held it in 2 quarters. The position peaked at $117K in Q2 2017. 1 fund tracked by Wall St. Rank holds SSRI as of Q3 2017.

  • Exane Derivatives reported no remaining Silver Standard Resources position as of Q3 2017 after selling out during the quarter.
  • Exane Derivatives sold 12,034 Silver Standard Resources shares in Q3 2017, an estimated $117K.
  • Exane Derivatives first reported a position in Silver Standard Resources in Q1 2017 and held it in 2 quarters.
  • Exane Derivatives's Silver Standard Resources position peaked at $117K in Q2 2017.
  • 1 fund tracked by Wall St. Rank held Silver Standard Resources as of Q3 2017.

Based on Exane Derivatives's 13F filing for Q3 2017, filed 18 Oct 2017.